Skip to content

Efficacy and safety evaluation of remimazolam in children receiving dental treatment

Efficacy and safety evaluation of remimazolam in children receiving dental treatment

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074131
Enrollment
Unknown
Registered
2023-07-31
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral diseases

Interventions

Remimazolam group:The initial dose of remimazolam was 0.3mg/kg, and 0.1mg/kg remimazolam was added which met MOAA/S=4 points
Midazolam group:The initial dose of midazolam group was 0.05mg /kg, and 0.01mg/kg midazolam was added which met MOAA/S=4 points

Sponsors

The Third Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 7 Years

Inclusion criteria

Inclusion criteria: 1. Patients receiving tooth extraction under sedation; 2. Aged 3 to 7 years; 3. 18 kg/m^2 = BMI =30 kg/m^2; 4. ASA I - II; 5. Informed consent got from patients.

Exclusion criteria

Exclusion criteria: 1 Children with history of neurological diseases and disability; 2 Children with history of respiratory or airway related diseases; 3. Children with difficult airway (Modified Mallampati score IV); 4. With severe systemic diseases and ASA level above ?; 5. With hepatic and kidney insufficiency; 6. Children with closed and open angle glaucoma 7. Known allergy to benzodiazepines or local anesthesia; 8. Children refusing treatment under sedation; 9. Children participating other clinical trials within the past three month.

Design outcomes

Primary

MeasureTime frame
Sedation success rate;Times to readiness for discharge after the end of the procedure;Complications related to medication;

Secondary

MeasureTime frame
Frankl Scale;Local anesthesia puncture and intraoperative pain VAS score;Time to peak sedation after administration of the first dose of medication;Time to local anesthesia after administration of the first dose of medication;Times to fully alert (first of 3 MOAA/S scores of 5 after end of the procedure) ;Times to fully alert (first of 3 MOAA/S scores of 5 after administration of the last dose of medication);Times to readiness for discharge after the last dose of the medication;Fluctuation of MOAA/S;Satisfaction of patients, dentists and anesthesiologists;Recovery quality evaluation;adverse events during the procedure;

Countries

China

Contacts

Public ContactHui ZHANG

The Third Affiliated Hospital of Air Force Medical University

zhanghuifmmua@163.com+86 139 9191 2266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026